Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989–2013: a multicentre prospective registration study
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
AIMS/HYPOTHESIS: Against a background of a near-universally increasing incidence of childhood type 1 diabetes, recent reports from some countries suggest a slowing in this increase. Occasional reports also describe cyclical variations in incidence, with periodicities of between 4 and 6 years. METHODS: Age/sex-standardised incidence rates for the 0- to 14-year-old age group are reported for 26 European centres (representing 22 countries) that have registered newly diagnosed individuals in geographically defined regions for up to 25 years during the period 1989-2013. Poisson regression was used to estimate rates of increase and test for cyclical patterns. Joinpoint regression software was used to fit segmented log-linear relationships to incidence trends. RESULTS: Significant increases in incidence were noted in all but two small centres, with a maximum rate of increase of 6.6% per annum in a Polish centre. Several centres in high-incidence countries showed reducing rates of increase in more recent years. Despite this, a pooled analysis across all centres revealed a 3.4% (95% CI 2.8%, 3.9%) per annum increase in incidence rate, although there was some suggestion of a reduced rate of increase in the 2004-2008 period. Rates of increase were similar in boys and girls in the 0- to 4-year-old age group (3.7% and 3.7% per annum, respectively) and in the 5- to 9-year-old age group (3.4% and 3.7% per annum, respectively), but were higher in boys than girls in the 10- to 14-year-old age group (3.3% and 2.6% per annum, respectively). Significant 4 year periodicity was detected in four centres, with three centres showing that the most recent peak in fitted rates occurred in 2012. CONCLUSIONS/INTERPRETATION: Despite reductions in the rate of increase in some high-risk countries, the pooled estimate across centres continues to show a 3.4% increase per annum in incidence rate, suggesting a doubling in incidence rate within approximately 20 years in Europe. Although four centres showed support for a cyclical pattern of incidence with a 4 year periodicity, no plausible explanation for this can be given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854
Self-citationIncidence trends of type 1 and type 2 diabetes among youths, 2002–2012
Mayer-Davis, E. J., Lawrence, J. M., Dabelea, D., Divers, J., Isom, S., Dolan, L., Imperatore, G., Linder, B., Marcovina, S., Pettitt, D. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1610187 · Cited by 1,476
Incidence and trends of childhood type 1 diabetes worldwide 1990–1999
The DIAMOND Project Group (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01925.x · Cited by 1,085
Morris, J. A., & Gardner, M. J. (1988) · BMJ · doi:10.1136/bmj.296.6632.1313 · Cited by 764
Measles Periodicity and Community Size
Bartlett, M. S. (1957) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2342553 · Cited by 718
Patterson, C. C., Gyürüs, E., Rosenbauer, J., Cinek, O., Neu, A., Schober, E., Parslow, R. C., Joner, G., Svensson, J., Castell, C., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2571-8 · Cited by 470
Self-citationDefinition, epidemiology and classification of diabetes in children and adolescents
Craig, M. E., Hattersley, A., & Donaghue, K. C. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00568.x · Cited by 461
Bingley, P. J., Bonifacio, E., Williams, A. J. K., Genovese, S., Bottazzo, G. F., & Gale, E. A. M. (1997) · Diabetes · doi:10.2337/diab.46.11.1701 · Cited by 461
Self-citationStudying seasonality by using sine and cosine functions in regression analysis.
Stolwijk, A. M., Straatman, H., & Zielhuis, G. A. (1999) · Journal of Epidemiology and Community Health · doi:10.1136/jech.53.4.235 · Cited by 443
Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study
Green, A., Gale, E. A. M., & Patterson, C. C. (1992) · The Lancet · doi:10.1016/0140-6736(92)90938-y · Cited by 407
Self-citation
Cited by
Lin, X., Xu, Y., Pan, X., Xu, J., Ding, Y., Sun, X., Song, X., Ren, Y., & Shan, P.-F. (2020) · Scientific Reports · doi:10.1038/s41598-020-71908-9 · Cited by 1,819
Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure
Eizirik, D. L., Pasquali, L., & Cnop, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0355-7 · Cited by 854
Patterson, C. C., Karuranga, S., Salpea, P., Saeedi, P., Dahlquist, G., Soltesz, G., & Ogle, G. D. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107842 · Cited by 560
Self-citationThe heterogeneous pathogenesis of type 1 diabetes mellitus
Ilonen, J., Lempainen, J., & Veijola, R. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0254-y · Cited by 494
Type 1 diabetes—early life origins and changing epidemiology
Norris, J. M., Johnson, R. K., & Stene, L. C. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30412-7 · Cited by 367
Ogle, G. D., James, S., Dabelea, D., Pihoker, C., Svennson, J., Maniam, J., Klatman, E. L., & Patterson, C. C. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109083 · Cited by 305
Self-citationLibman, I., Haynes, A., Lyons, S., Pradeep, P., Rwagasor, E., Tung, J. Y., Jefferies, C. A., Oram, R. A., Dabelea, D., & Craig, M. E. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13454 · Cited by 285
Wagenknecht, L. E., Lawrence, J. M., Isom, S., Jensen, E. T., Dabelea, D., Liese, A. D., Dolan, L. M., Shah, A. S., Bellatorre, A., Sauder, K., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00025-6 · Cited by 264
New frontiers in the treatment of type 1 diabetes
Warshauer, J. T., Bluestone, J. A., & Anderson, M. S. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.017 · Cited by 259
“Finland and Norway) appear to be levelling off (Patterson et al., 2019).”
BackgroundEstatística Cardiovascular – Brasil 2021
Oliveira, G. M. M. D., Brant, L. C. C., Polanczyk, C. A., Malta, D. C., Biolo, A., Nascimento, B. R., Souza, M. D. F. M. D., Lorenzo, A. R. D., Fagundes, A. A. D. P., Schaan, B. D., et al. (2022) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20211012 · Cited by 253
Nimri, R., Battelino, T., Laffel, L. M., Slover, R. H., Schatz, D., Weinzimer, S. A., Dovc, K., Danne, T., Phillip, M., NextDREAM Consortium, et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1045-7 · Cited by 242
Self-citationInsufficient Sun Exposure Has Become a Real Public Health Problem
Alfredsson, L., Armstrong, B. K., Butterfield, D. A., Chowdhury, R., de Gruijl, F. R., Feelisch, M., Garland, C. F., Hart, P. H., Hoel, D. G., Jacobsen, R., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17145014 · Cited by 164
Probiotics and prebiotics for the amelioration of type 1 diabetes: Present and future perspectives
Mishra, S., Wang, S., Nagpal, R., Miller, B., Singh, R., Taraphder, S., & Yadav, H. (2019) · Microorganisms · doi:10.3390/microorganisms7030067 · Cited by 131
Goldenberg, R. M., Gilbert, J. D., Hramiak, I. M., Woo, V. C., & Zinman, B. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13811 · Cited by 114
Weisman, A., Tu, K., Young, J., Kumar, M., Austin, P. C., Jaakkimainen, L., Lipscombe, L., Aronson, R., & Booth, G. L. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001224 · Cited by 62
Musso, G., Sircana, A., Saba, F., Cassader, M., & Gambino, R. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003461 · Cited by 61
“Patients with T1DM need adjunctive therapies to improve glycemic control and mitigate unwanted effects of insulin [1,2,3].”
BackgroundArffman, M., Hakkarainen, P., Keskimäki, I., Oksanen, T., & Sund, R. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110580 · Cited by 58
Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?
Snaith, J. R., Holmes-Walker, D. J., & Greenfield, J. R. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.11.007 · Cited by 45
Geirhos, A., Domhardt, M., Lunkenheimer, F., Temming, S., Holl, R. W., Minden, K., Warschburger, P., Meissner, T., Mueller-Stierlin, A. S., & Baumeister, H. (2022) · BMC Pediatrics · doi:10.1186/s12887-022-03134-3 · Cited by 37
“In recent decades the incidence rate increased [2].”
BackgroundRao, L., Ren, C., Luo, S., Huang, C., & Li, X. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01686-x · Cited by 29
(2024) · Journal of Community Medicine & Public Health · doi:10.29011/2577-2228.100460 · Cited by 19
Gajewska, K. A., Biesma, R., Sreenan, S., & Bennett, K. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-032916 · Cited by 15
Kwa, T., Zhang, G., Shepard, K., Wherry, K., & Chattaraj, S. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.1945784 · Cited by 11
Incidencia de la diabetes mellitus tipo 1 en Asturias entre 2011 y 2020
Rodríguez Escobedo, R., Delgado Álvarez, E., & Menéndez Torre, E. L. (2023) · Endocrinología, Diabetes y Nutrición · doi:10.1016/j.endinu.2022.11.005 · Cited by 6
Metadata
- Authors
- Patterson, C. C., Harjutsalo, V., Rosenbauer, J., Neu, A., Cinek, O., Skrivarhaug, T., Rami-Merhar, B., Soltesz, G., Svensson, J., Parslow, R. C., Castell, C., Schoenle, E. J., Bingley, P. J., Dahlquist, G., Jarosz-Chobot, P. K., Marčiulionytė, D., Roche, E. F., Rothe, U., Bratina, N., Ionescu-Tirgoviste, C., Weets, I., Kocova, M., Cherubini, V., Rojnic Putarek, N., deBeaufort, C. E., Samardzic, M., & Green, A.
- Venue
- Diabetologia
- Published
- 2018-11-28
- Volume
- 62
- Issue
- 3
- Pages
- 408-417
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2900756670
- Cited by
- 512
- References
- 32
- FWCI
- 26.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.